WI
Whitney Ijem Canaccord Genuity Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
PVLA
1
Palvella Therapeutics, Inc. Common Stock
PVLA
$616M
| $55.68 | $66 |
19%
upside
| Buy | 18 days ago |
|
2
Taysha Gene Therapies
TSHA
$917M
| $3.36 | $14 |
317%
upside
| Buy | 25 days ago |
|
3
Ultragenyx Pharmaceutical
RARE
$3.07B
| $31.82 | $128 |
302%
upside
| Buy | 29 days ago |
|
4
Vertex Pharmaceuticals
VRTX
$102B
| $396.12 | $411 |
4%
upside
| Hold | 1 month ago |
|
5
Wave Life Sciences
WVE
$1.32B
| $8.29 | $19 |
129%
upside
| Buy | 1 month ago |
|
6
Alnylam Pharmaceuticals
ALNY
$59.2B
| $452 | $415 |
8%
downside
| Buy | 1 month ago |
|
7
Rocket Pharmaceuticals
RCKT
$354M
| $3.28 | $10 |
205%
upside
| Buy | 1 month ago |
|
8
Rhythm Pharmaceuticals
RYTM
$6.78B
| $102.12 | $105 |
3%
upside
| Buy | 1 month ago |
|
9
Intellia Therapeutics
NTLA
$1.29B
| $12.06 | $54 |
348%
upside
| Buy | 3 months ago |
|
10
Arcturus Therapeutics
ARCT
$485M
| $17.85 | $66 |
270%
upside
| Buy | 3 months ago |
|
11
Sarepta Therapeutics
SRPT
$1.96B
| $18.71 | $150 |
702%
upside
| Buy | 10 months ago |
|
12
BioMarin Pharmaceuticals
BMRN
$11.1B
| $57.77 | $84 |
45%
upside
| Hold | 10 months ago |
|
|
13
Arcturus Therapeutics
ARCT
$485M
| $17.85 | $19 |
6%
upside
| Buy | 5 years ago |
|